Skip to main content
. 2013 Jun 13;2013:657016. doi: 10.1155/2013/657016

(b)

Treatments in 87 patients with primary lesions, n = patients, n/87 = (%)
Treatments Doses Remission Remission weeks
SRa 31, (35.63) None (100%) 7.41 ± 2.71
Glub 37, (42.52) 24.54 ± 15.07 35/37, (94.59%) 9.02 ± 5.04
VTc 19, (21.83) 6.36 ± 3.41 (100%) 7.40 ± 2.70

aSR: spontaneous remission. bGlu: meglumine antimoniate or Glucantime.

cVT: Leishmania amastigotes (La, Lv, Lb, and Lch) after TLCK treatment and NP-40 extraction.